Back to search results
NCT07111052

Lock and Protect: Reducing Adolescent Access to Lethal Means of Suicide

Enrolling by Invitation
NAAges 13–17InterventionalPrevention
Columbia University
~50 participants
Updated 2025-12-05 on ClinicalTrials.gov
What's tested:Lock and Protect is a self-administered, web-based decision aid for caregivers of adolescents at risk for suicide.

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of caregivers who improved home storage of medications and/or firearms
Measured over Baseline (ED visit), 1 month follow-up

Conditions

Suicide
Suicide Attempt
Adolescent Suicidality
Suicide Ideation

Explore related trials

Non-Suicidal Self-InjurySuicidal IdeationSuicide Attempt

NCT07111052

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Morgan Stanley Children's Hospital, Pediatric Emergency

    New York, New Yorkno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Ashley Blanchard, MD, MS · PRINCIPAL_INVESTIGATOR · Columbia University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Parents or caregivers of adolescents aged 13-17 years presenting to the ED for suicidal thoughts and/or behaviors or non-suicidal self-injury as defined by presenting complaint or initial provider assessment.
Patients ages 13-17 years-old presenting to the ED for non-suicidal self-injury (NSSI), suicidal thoughts and behaviors

Exclusion

Medically unstable children
Patients with autism, intellectual disability, or active psychosis
Lack of parental and/or youth English and/or Spanish fluency
Caregivers who do not reside in the same home as the patient for at least 2 nights a week
If the caregiver OR patient does not agree to participation both participants will be excluded

What this trial measures

  • Proportion of caregivers who improved home storage of medications and/or firearmsBaseline (ED visit), 1 month follow-up

    The primary efficacy outcome is change in home access to medications and/or firearms by 1-month post-discharge from the ED, as measured by a REDCap self-administered survey.